Syntheticdesignlab

2 known investors

Synthetic Design Lab develops engineered therapeutic platforms and AI-driven antibody design technologies for precision medicine and cancer immunotherapy. The company builds protein engineering and antibody drug conjugate solutions for pharmaceutical development.